Literature DB >> 27110842

Applicability of the comet assay in evaluation of DNA damage in healthcare providers' working with antineoplastic drugs: a systematic review and meta-analysis.

Mohammad Javad Zare Sakhvidi1, Mohammad Hajaghazadeh2, Mehrdad Mostaghaci3, Amir Houshang Mehrparvar3, Fariba Zare Sakhvidi4, Elham Naghshineh5.   

Abstract

BACKGROUND: Unintended occupational exposure to antineoplastic drugs (ANDs) may occur in medical personnel. Some ANDs are known human carcinogens and exposure can be monitored by genotoxic biomarkers.
OBJECTIVE: To evaluate the obstacles to obtaining conclusive results from a comet assay test to determine DNA damage among AND exposed healthcare workers.
METHODS: We systematically reviewed studies that used alkaline comet assay to determine the magnitude and significance of DNA damage among health care workers with potential AND exposure. Fifteen studies were eligible for review and 14 studies were used in the meta-analysis.
RESULTS: Under random effect assumption, the estimated standardized mean difference (SMD) in the DNA damage of health care workers was 1.93 (95% CI: 1.15-2.71, p < 0.0001). The resulting SMD was reduced to 1.756 (95% CI: 0.992-2.52, p < 0.0001) when the analysis only included nurses. In subgroup analyses based on gender and smoking, heterogeneity was observed. Only for studies reporting comet moment, I2 test results, as a measure of heterogeneity, dropped to zero. Heterogeneity analysis showed that date of study publication was a possible source of heterogeneity (B = -0.14; p < 0.0001).
CONCLUSIONS: A mixture of personal parameters, comet assay methodological variables, and exposure characteristics may be responsible for heterogenic data from comet assay studies and interfere with obtaining conclusive results. Lack of quantitative environmental exposure measures and variation in comet assay protocols across studies are important obstacles in generalization of results.

Entities:  

Keywords:  Antineoplastic drugs; Comet assay; DNA damage; Genotoxicity; Health care workers; Occupational exposure

Mesh:

Substances:

Year:  2016        PMID: 27110842      PMCID: PMC4894275          DOI: 10.1080/10773525.2015.1123380

Source DB:  PubMed          Journal:  Int J Occup Environ Health        ISSN: 1077-3525


  64 in total

1.  Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists.

Authors:  Ahmad A El-Ebiary; Arwa A Abuelfadl; Naglaa I Sarhan
Journal:  J Appl Toxicol       Date:  2011-09-21       Impact factor: 3.446

2.  The genetic toxicity of time: importance of DNA-unwinding time to the outcome of single-cell gel electrophoresis assays.

Authors:  J E Yendle; H Tinwell; B M Elliott; J Ashby
Journal:  Mutat Res       Date:  1997-04-29       Impact factor: 2.433

3.  Molecular biomonitoring of a population of nurses handling antineoplastic drugs.

Authors:  Tommaso Cornetta; Luca Padua; Antonella Testa; Elena Ievoli; Fabiola Festa; Giovanna Tranfo; Luigi Baccelliere; Renata Cozzi
Journal:  Mutat Res       Date:  2007-09-07       Impact factor: 2.433

4.  Human effect monitoring in cases of occupational exposure to antineoplastic drugs: a method comparison.

Authors:  S Kevekordes; T W Gebel; M Hellwig; W Dames; H Dunkelberg
Journal:  Occup Environ Med       Date:  1998-03       Impact factor: 4.402

5.  An ECVAG inter-laboratory validation study of the comet assay: inter-laboratory and intra-laboratory variations of DNA strand breaks and FPG-sensitive sites in human mononuclear cells.

Authors:  Clara Ersson; Peter Møller; Lykke Forchhammer; Steffen Loft; Amaya Azqueta; Roger W L Godschalk; Frederik-Jan van Schooten; George D D Jones; Jennifer A Higgins; Marcus S Cooke; Vilas Mistry; Mahsa Karbaschi; David H Phillips; Osman Sozeri; Michael N Routledge; Kirsty Nelson-Smith; Patrizia Riso; Marisa Porrini; Giuseppe Matullo; Alessandra Allione; Maciej Stepnik; Magdalena Ferlińska; João Paulo Teixeira; Solange Costa; Laura-Ana Corcuera; Adela López de Cerain; Blanca Laffon; Vanessa Valdiglesias; Andrew R Collins; Lennart Möller
Journal:  Mutagenesis       Date:  2013-02-27       Impact factor: 3.000

6.  Mutagenicity in urine of nurses handling cytostatic drugs.

Authors:  K Falck; P Gröhn; M Sorsa; H Vainio; E Heinonen; L R Holsti
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

7.  Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.

Authors:  M Hedmer; H Tinnerberg; A Axmon; B A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-12-08       Impact factor: 3.015

8.  A history of cancer chemotherapy.

Authors:  Vincent T DeVita; Edward Chu
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

9.  DNA-damaging effect of cyclophosphamide on human blood cells in vivo and in vitro studied with the single-cell gel test (comet assay).

Authors:  A Hartmann; K Herkommer; M Glück; G Speit
Journal:  Environ Mol Mutagen       Date:  1995       Impact factor: 3.216

10.  Evaluation of surface contamination with cyclophosphamide following simulated hazardous drug preparation activities using two closed-system products.

Authors:  Matthew D Zock; Scott Soefje; Keith Rickabaugh
Journal:  J Oncol Pharm Pract       Date:  2010-06-28       Impact factor: 1.809

View more
  2 in total

Review 1.  Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs.

Authors:  Christine Roussel; Kristine L Witt; Peter B Shaw; Thomas H Connor
Journal:  Mutat Res Rev Mutat Res       Date:  2017-08-24       Impact factor: 5.657

2.  Safe Handling of Antineoplastic Drugs During Allergy Diagnostic Workup and Desensitization: A Single Experience of the Allergy Department in a Tertiary Hospital.

Authors:  María Pilar Berges-Gimeno; Cristina Pueyo López; Alicia Barra-Castro; Emilio Solano Solares; Belén de la Hoz Caballer
Journal:  Front Allergy       Date:  2022-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.